JPWO2020262555A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020262555A5 JPWO2020262555A5 JP2021527744A JP2021527744A JPWO2020262555A5 JP WO2020262555 A5 JPWO2020262555 A5 JP WO2020262555A5 JP 2021527744 A JP2021527744 A JP 2021527744A JP 2021527744 A JP2021527744 A JP 2021527744A JP WO2020262555 A5 JPWO2020262555 A5 JP WO2020262555A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- pharmaceutical composition
- composition according
- double
- stranded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019120908 | 2019-06-28 | ||
| PCT/JP2020/025093 WO2020262555A1 (ja) | 2019-06-28 | 2020-06-25 | 核酸医薬副作用軽減剤、該核酸医薬副作用軽減剤を含む医薬組成物、並びに核酸医薬の副作用惹起性を軽減する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2020262555A1 JPWO2020262555A1 (https=) | 2020-12-30 |
| JPWO2020262555A5 true JPWO2020262555A5 (https=) | 2022-06-02 |
Family
ID=74061653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021527744A Pending JPWO2020262555A1 (https=) | 2019-06-28 | 2020-06-25 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2020262555A1 (https=) |
| WO (1) | WO2020262555A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6300212B2 (ja) * | 2013-03-21 | 2018-03-28 | 国立大学法人 東京医科歯科大学 | 二重鎖核酸結合剤、当該結合剤−二重鎖核酸複合体、当該複合体を含有する医薬品組成物、及び、当該複合体の製造方法 |
| US11345914B2 (en) * | 2017-07-11 | 2022-05-31 | Tokyo University Of Pharmacy And Life Sciences | Composition for delivering nucleic acid and nucleic acid-containing composition |
-
2020
- 2020-06-25 JP JP2021527744A patent/JPWO2020262555A1/ja active Pending
- 2020-06-25 WO PCT/JP2020/025093 patent/WO2020262555A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2440566A1 (en) | CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS | |
| US9163235B2 (en) | Inhibitors of the miR-15 family of micro-RNAs | |
| JP2022528487A5 (https=) | ||
| JP2018529732A5 (https=) | ||
| JPWO2023022229A5 (https=) | ||
| JP2023138687A (ja) | Ｂ型肝炎感染の治療用のＰＡＰＤ５及びＰＡＰＤ７ ｍＲＮＡを低減させるための核酸分子 | |
| JP2015523853A5 (https=) | ||
| JP2010532163A5 (https=) | ||
| JP2023500661A5 (https=) | ||
| JP2024512635A5 (https=) | ||
| JP2023526090A5 (https=) | ||
| WO2017068791A1 (ja) | 少なくとも１つのバルジ構造を有する核酸複合体 | |
| AU2022352668A1 (en) | Double stranded oligonucleotide compositions and methods relating thereto | |
| JPWO2020262555A5 (https=) | ||
| JP2024542738A5 (https=) | ||
| JP2024528252A (ja) | 核酸医薬の徐放性能の強化方法 | |
| EP2356234B1 (en) | Dosage of oligonucleotides suitable for the treatment of tumors | |
| WO2024212954A1 (zh) | 抑制lpa基因表达的化合物、药物组合物及其用途 | |
| WO2019183005A1 (en) | 2'f-ana-let7 mediated utrophin upregulation for dmd therapy | |
| JP2025504474A5 (https=) | ||
| WO2021107143A1 (ja) | アンチセンス核酸の毒性を軽減する方法 | |
| Alvira et al. | Triplex-stabilizing properties of parallel clamps carrying LNA derivatives at the Hoogsteen strand | |
| JPWO2023042876A5 (https=) | ||
| KR20240110595A (ko) | 안정화된 rna 제제 | |
| WO2008109493A4 (en) | NUCLEIC ACID COMPOUNDS DESIGNED TO INHIBIT EXPRESSION OF CD19 GENE AND USES THEREOF |